Lipella Pharmaceuticals sells substantially all assets to XRAIY in Chapter 11 liquidation
Lipella Pharmaceuticals Inc., which filed for Chapter 11 bankruptcy on March 30, 2026, sold substantially all of its assets to XRAIY LLC pursuant to an Asset…
$205,000$3.2M